Design and development of reactive injectable and settable polymeric biomaterials

Journal of Biomedical Materials Research - Part A

Volumn 101, Issue 12, 2013, Pages 3630-3645

  Page, Jonathan M ^a,b   Harmata, Andrew J ^a,b   Guelcher, Scott A ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

biocompatibility; biomaterials; injectable; settable

Indexed keywords

CLINICAL TRANSLATION; DESIGN AND DEVELOPMENT; ENGINEERING CHALLENGES; INJECTABLE; POLYMERIC BIOMATERIALS; REGENERATIVE MEDICINE; SETTABLE; SURGICAL PROCEDURES;

BIOCOMPATIBILITY; BIOMATERIALS; POLYMERS;

BIOLOGICAL MATERIALS;

AMALGAM; BIOMATERIAL; CALCIUM CARBONATE; CARBON DIOXIDE; CASTOR OIL; CYANOACRYLATE DERIVATIVE; CYANOACRYLIC ACID OCTYL ESTER; ETHYLENE OXIDE; FIBRIN; FIBRIN GLUE; HYALURONIC ACID; ISOCYANATE; ISOCYANIC ACID DERIVATIVE; METHACRYLIC ACID DERIVATIVE; MONOMER; POLY(METHYL METHACRYLATE); POLYGLACTIN; POLYMER; POLYURETHAN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TOLUENE DIISOCYANATE;

AUTOCLAVE; BACTERIAL INFECTION; BIOCOMPATIBILITY; CLICK CHEMISTRY; DEGRADATION; FILTRATION; GAMMA IRRADIATION; HOMEOSTASIS; HUMAN; HYDROGEL; INFRARED SPECTROSCOPY; INSTRUMENT STERILIZATION; POLYMERIZATION; REVIEW; TISSUE REGENERATION; WOUND CLOSURE;

BIOCOMPATIBILITY; BIOMATERIALS; INJECTABLE; SETTABLE;

BIOCOMPATIBLE MATERIALS; INJECTIONS; MATERIALS TESTING; POLYMERS;

EID: 84886721194     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34665     Document Type: Review

References (230)

1. Ratner BD, Bryant SJ,. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng 2004; 6: 41-75.
2. Donaruma LG,. Definitions in biomaterials, D. F. Williams, Ed., Elsevier, Amsterdam, 1987, 72 pp.
3. Donaruma LG,. J Polym Sci Part C 1988; 26 (9): 414-414.
4. ASTM F2150-02, in Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products. West Conshohocken, PA: ASTM International. http://www.astm.org/Msgs/citing.htm.
5. Migliaresi C, Motta A, DiBenedetto AT,. Engineering Functional Skeletal Tissues. Injectable scaffolds for bone and cartilage regeneration. Eng Funct Skeletal Tissues 2007: 95-109.
6. Williams DF,. On the nature of biomaterials. Biomaterials 2009; 30 (30): 5897-5909.
7. Bohner M,. Design of ceramic-based cements and putties for bone graft substitution. Eur Cells Mater 2010; 20: 1-12.
8. Campoccia D, Montanaro L, Arciola CR,. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 2006; 27 (11): 2331-2339.
9. Gristina AG,. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987; 237 (4822): 1588-1595.
10. Lysaght MJ, Jaklenec A, Deweerd E,. Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng Part A 2008; 14 (2): 305-315.
11. Domb AJ, Kumar N,. Biodegradable Polymers in Clinical Use and Clinical Development. Hoboken, NJ, Wiley; 2011.
12. Vernon B,. Injectable Biomaterials: science and Applications. Cambridge, UK, Woodhead Publishing; 2011.
13. Li Y, Rodrigues J, Tomas H,. Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. Chem Soc Rev 2012; 41 (6): 2193-2221.
14. Nguyen MK, Lee DS,. Injectable biodegradable hydrogels. Macromol Biosci 2010; 10 (6): 563-579.
15. Guelcher SA,. Biodegradable polyurethanes: synthesis and applications in regenerative medicine. Tissue Eng Part B Rev 2008; 14 (1): 3-17.
16. Kolb HC, Finn MG, Sharpless KB,. Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed 2001; 40 (11): 2004-2021.
17. Moreira Teixeira LS, Feijen J, van Blitterswijk CA, Dijkstra PJ, Karperien M,. Enzyme-catalyzed crosslinkable hydrogels: emerging strategies for tissue engineering. Biomaterials 2012; 33 (5): 1281-1290.
18. Wataha JC,. Predicting clinical biological responses to dental materials. Dental Mater 2012; 28 (1): 23-40.
19. Cartland RF Jr,. The US Dental Amalgam Debate, 2010 Meeting of the FDA Dental Products Panel. 2011.
20. Anusavice KJ,. Phillips' Science of Dental Materials. Vol. 11. St. Louis, MO, Saunders Amsterdam; 2003.
21. Ramesh B, Kulvider W, Aseem T, Anil C,. Dental amalgam: an update. J Conserv Dent 13 (4): 204-208.
22. Rueggeberg FA,. From vulcanite to vinyl, a history of resins in restorative dentistry. J Prosthet Dent 2002; 87 (4): 364-379.
23. Stansbury JW,. Curing dental resins and composites by photopolymerization. J Esthet Restorat Dent 2000; 12 (6): 300-308.
24. Beazoglou T, Eklund S, Heffley D, Meiers J, Brown LJ, Bailit H,. Economic impact of regulating the use of amalgam restorations. Public Health Rep 2007; 122 (5): 657.
25. Omstead DR, Baird LG, Christenson L, Moulin GD, Tubo R, Maxted DD, Davis J, Gentile FT,. Voluntary guidance for the development of tissue-engineered products. Tissue Eng 1998; 4 (3): 239-266.
26. Anderson JM,. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol 1993; 2 (3): 33-41.
27. Belt H, Neut D, Schenk W, Horn JR, Mei C, Busscher HJ,. Infection of orthopedic implants and the use of antibiotic-loaded bone cements: a review. Acta Orthop 2001; 72 (6): 557-571.
28. Schierholz JM, Beuth J,. Implant infections: a haven for opportunistic bacteria. J Hosp Infect 2001; 49 (2): 87-93.
29. Rimondini L, Fini M, Giardino R,. The microbial infection of biomaterials: a challenge for clinicians and researchers. A short review. J Appl Biomater Biomech 2005; 3 (1): 1-10.
30. Safdar N, Kluger DM, Maki DG,. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine 2002; 81 (6): 466-479.
31. Fray ME, Barthkowiak A, Prowans P, Slonecki J,. Physical and mechanical behavior of electron-beam irradiated and ethylene oxide sterilized multiblock polyester. J Mater Sci 2000; 11 (11): 757-762.
32. Mendes GCC, Brandão TRS, Silva CLM,. Ethylene oxide sterilization of medical devices: a review. Am J Infect Control 2007; 35 (9): 574-581.
33. Benson RS,. Use of radiation in biomaterials science. Nucl Instrum Methods Phys Res B 2002; 191 (1-4): 752-757.
34. Adams SB Jr, Shamji MF, Nettles DL, Hwang P, Setton LA,. Sustained release of antibiotics from injectable and thermally responsive polypeptide depots. J Biomed Mater Res B Appl Biomater 2009; 90 (1): 67-74.
35. Guelcher SA, Brown KV, Li B, Guda T, Lee BH, Wenke JC,. Dual-purpose bone grafts improve healing and reduce infection. J Orthop Trauma 2011; 25 (8): 477-482.
36. Hafeman AE, Zienkiewicz KJ, Carney E, Litzner B, Stratton C, Wenke JC, Guelcher SA,. Local delivery of tobramycin from injectable biodegradable polyurethane scaffolds. J Biomater Sci Polym Ed 2010; 21 (1): 95-112.
37. Ji QX, Chen XG, Zhao QS, Liu CS, Cheng XJ, Wang LC,. Injectable thermosensitive hydrogel based on chitosan and quaternized chitosan and the biomedical properties. J Mater Sci Mater Med 2009; 20 (8): 1603-1610.
38. Leprêtre S, Chai F, Hornez JC, Vermet G, Neut C, Descaps M, Hildebrand HF, Martel B,. Prolonged local antibiotics delivery from hydroxyapatite functionalised with cyclodextrin polymers. Biomaterials 2009; 30 (30): 6086-6093.
39. Li B, Brown KV, Wenke JC, Guelcher SA,. Sustained release of vancomycin from polyurethane scaffolds inhibits infection of bone wounds in a rat femoral segmental defect model. J Control Release 2010; 145 (3): 221-230.
40. Prestwich GD, Luo Y,. Novel biomaterials for drug delivery. Exp Opin Therap Patents 2001; 11 (9): 1395-1410.
41. Shi M, Kretlow JD, Spicer PP, Tabata Y, Demian N, Wong ME, Kasper FK, Mikos AG,. Antibiotic-releasing porous polymethylmethacrylate/gelatin/antibiotic constructs for craniofacial tissue engineering. J Control Release 2011; 152 (1): 196-205.
42. Wenke JC, Guelcher SA,. Dual delivery of an antibiotic and a growth factor addresses both the microbiological and biological challenges of contaminated bone fractures. Exp Opin Drug Deliv 2011; 8 (12): 1555-1569.
43. Campoccia D, Montanaro L, Speziale P, Arciola CR,. Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials 2010; 31 (25): 6363-6377.
44. Desgranges S, Ruddle CC, Burke LP, McFadden TM, O'Brien JE, Fitzgerald-Huges D, Humphreys H, Smyth TP, Devocelle M,. β-Lactam-host defence peptide conjugates as antibiotic prodrug candidates targeting resistant bacteria. RSC Adv. 2012; 2: 2480-2492.
45. Suzuki Y, Tanihara M, Nishimura Y, Suzuki K, Kakimaru Y, Shimizu Y,. A new drug delivery system with controlled release of antibiotic only in the presence of infection. J Biomed Mater Res 1998; 42 (1): 112-116.
46. Zheng Z, Yin W, Zara JN, Li W, Kwak J, Mamidi R, Lee M, Siu RK, Ngo R, Wang J,. The use of BMP-2 coupled-Nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects. Biomaterials 2010; 31 (35): 9293-9300.
47. Stewart R, Goldstein J, Eberhardt A, Gabriel Chu GTM, Gilber S,. Increasing vascularity to improve healing of a segmental defect of the rat femur. J Orthop Trauma 2011; 25 (8): 472-476.
48. Martin JL, Norris BJ, Murphy E, Crowe JA,. Medical device development: the challenge for ergonomics. Appl Ergon 2008; 39 (3): 271-283.
49. Gupta RK,. Polymer and Composite Rheology. Vol. 58. CRC; 2000. New York, NY.
50. Baroud G, Cayer E, Bohner M,. Rheological characterization of concentrated aqueous β-tricalcium phosphate suspensions: the effect of liquid-to-powder ratio, milling time, and additives. Acta Biomater 2005; 1 (3): 357-363.
51. Dumas JE, BrownBaer PB, Prieto EM, Guda T, Hale RG, Wenke JC, Guelcher SA,. Injectable reactive biocomposites for bone healing in critical-size rabbit calvarial defects. Biomed Mater 2012; 7 (2): 024112.
52. Liu C, Shao H, Chen F, Zheng H,. Rheological properties of concentrated aqueous injectable calcium phosphate cement slurry. Biomaterials 2006; 27 (29): 5003-5013.
53. Habib M, Baroud G, Gitzhofer G, Bohner M,. Mechanisms underlying the limited injectability of hydraulic calcium phosphate paste. Acta Biomater 2008; 4 (5): 1465-1471.
54. Page JM, et al., Biocompatibility and chemical reaction kinetics of injectable, settable polyurethane/allograft bone biocomposites. Acta Biomater 2012; 8 (12): 4405-4416.
55. Sarvestani AS, He X, Jabbari E,. Viscoelastic characterization and modeling of gelation kinetics of injectable in situ cross-linkable poly (lactide-co-ethylene oxide-co-fumarate) hydrogels. Biomacromolecules 2007; 8 (2): 406-415.
56. Småbrekke A, Espehaug B, Havelin L, Furnes O,. Operating time and survival of primary total hip replacements an analysis of 31 745 primary cemented and uncemented total hip replacements from local hospitals reported to the Norwegian Arthroplasty Register 1987-2001. Acta Orthop 2004; 75 (5): 524-532.
57. Leeson MC, Lippitt SB,. Thermal aspects of the use of polymethylmethacrylate in large metaphyseal defects in bone: a clinical review and laboratory study. Clin Orthop Relat Res 1993; 295: 239.
58. Radev BR, Kase JA, Askew MJ, Weiner SD,. Potential for thermal damage to articular cartilage by PMMA reconstruction of a bone cavity following tumor excision: a finite element study. J Biomech 2009; 42 (8): 1120-1126.
59. Lador R, Dreiangel N, Ben-Galim PJ, Hipp JA,. A pictorial classification atlas of cement extravasation with vertebral augmentation. Spine J 2010; 10 (12): 1118-1127.
60. Rodrigues D, Gilbert J, Hasenwinkel J,. Pseudoplasticity and setting properties of two-solution bone cement containing poly (methyl methacrylate) microspheres and nanospheres for kyphoplasty and vertebroplasty. J Biomed Mater Res Part B Appl Biomater 2009; 91 (1): 248-256.
61. ISO. Biological Evaluations of Medical Devices, in Tests for In Vitro Cytotoxicity 2009(E). ISO: Geneva, Switzerland.
62. Hubbell JA,. Biomaterials in tissue engineering. Nat Biotechnol 1995; 13 (6): 565-576.
63. Göpferich A, Mechanisms of polymer degradation and erosion. Biomaterials 1996; 17 (2): 103-114.
64. Vert M, Li S, Spenlehauer G, Guerin P,. Bioresorbability and biocompatibility of aliphatic polyesters. J Mater Sci Mater Med 1992; 3 (6): 432-446.
65. Antheunis H, van der Meer JC, de Gues M, Kingma W, Koning CE,. Improved mathematical model for the hydrolytic degradation of aliphatic polyesters. Macromolecules 2009; 42 (7): 2462-2471.
66. Gunatillake PA, Adhikari R,. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater 2003; 5 (1): 1-16.
67. Lutolf MP, Hubbell JA,. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotech 2005; 23 (1): 47-55.
68. Hsu CW, Olabisi RM, Olmsted-Davis EA, Davis AR, West JL,. Cathepsin K-sensitive poly(ethylene glycol) hydrogels for degradation in response to bone resorption. J Biomed Mater Res Part A 2011; 98A (1): 53-62.
69. West JL, Hubbell JA,. Photopolymerized hydrogel materials for drug delivery applications. React Polym 1995; 25 (2-3): 139-147.
70. Pawar RP, Jadhave AE, Tathe SB, Khade BC, Domb AJ,. Medicinal Applications of Cyanoacrylate, in Biodegradable Polymers in Clinical Use and Clinical Development. John Wiley & Sons, Inc.; 2011. p. 417-449.
71. Singer AJ, Quinn JV, Hollander JE,. The cyanoacrylate topical skin adhesives. Am J Emerg Med 2008; 26 (4): 490-496.
72. Leonard F, Kulkarni RK, Brandes G, Nelson J, Cameron JJ,. Synthesis and degradation of poly (alkyl α-cyanoacrylates). J Appl Polym Sci 1966; 10 (2): 259-272.
73. Toriumi Dm RWFFMTM,. Histotoxicity of cyanoacrylate tissue adhesives: a comparative study. Archiv Otolaryngol Head Neck Surg 1990; 116 (5): 546-550.
74. Mattamal GJ,. US FDA perspective on the regulations of medical-grade polymers: cyanoacrylate polymer medical device tissue adhesives. Exp Rev Med Devices 2008; 5 (1): 41-49.
75. Eaglstein WH, Sullivan T,. Cyanoacrylates for skin closure. Dermatol Clin 2005; 23 (2): 193-198.
76. Spiegel S, Vi F, Goldwasser J, Fox A, Pelz D,. Adjusting the polymerization time of isobutyl-2 cyanoacrylate. Am J Neuroradiol 1986; 7 (1): 109-112.
77. Levitsky S, James PM, Anderson RW, Hardaway R,. Vascular trauma in Vietnam battle casualties: an analysis of 55 consecutive cases. Ann Surg 1968; 168 (5): 831.
78. Forseth M, O'Grady K, Toriumi D,. The current status of cyanoacrylate and fibrin tissue adhesives. J Long Term Eff Med Implants 1992; 2 (4): 221.
79. Seewald S, Ang TL, Imazu H, Naga M, Omar S, Groth S, Seitz U, Zhong Y, Thonke F, Soehendra N,. A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos). Gastrointest Endosc 2008; 68 (3): 447-454.
80. Nguyen KT, West JL,. 2-Octyl-cyanoacrylate (Dermabond), a new glue for variceal injection therapy: results of a preliminary animal study. Gastrointest Endosc 2002; 55 (4): 572-575.
81. Baroli B,. Photopolymerization of biomaterials: issues and potentialities in drug delivery, tissue engineering, cell encapsulation applications. J Chem Technol Biotechnol 2006; 81 (4): 491-499.
82. Ifkovits JL, Burdick JA,. Review: photopolymerizable and degradable biomaterials for tissue engineering applications. Tissue Eng 2007; 13 (10): 2369-2385.
83. Nguyen KT, West JL,. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 2002; 23 (22): 4307-4314.
84. Anseth KS, Burdick JA,. New directions in photopolymerizable biomaterials. MRS Bull Mater Res Soc 2002; 27 (2): 130-138.
85. Burkoth AK, Anseth KS,. A review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials 2000; 21 (23): 2395-2404.
86. Fisher JP, Dean D, Engel PS, Mikos AG,. Photoinitiated polymerization of biomaterials. Ann Rev Mater Res 2001; 31 (1): 171-181.
87. Elisseeff J, Anseth K, Sims D, McIntosh W, Randolph M, Yaremchuk M, Langer R,. Transdermal photopolymerization of poly (ethylene oxide)-based injectable hydrogels for tissue-engineered cartilage. Plast Reconstruct Surg 1999; 104 (4): 1014.
88. Alleyne CH Jr, Cawley CM, Barrow DL, Poff BC, Powell MD, Sawhney AS, Dillehay DL,. Efficacy and biocompatibility of a photopolymerized, synthetic, absorbable hydrogel as a dural sealant in a canine craniotomy model. J Neurosurg 1998; 88 (2): 308-313.
89. Park EL, Ulreich JB, Scott KM, Ullrich F, Linehan JA, French MH, Ho WY, White MJN, Talley JR, Fellah AM, Ramakumar S,. Evaluation of polyethylene glycol based hydrogel for tissue sealing after laparoscopic partial nephrectomy in a porcine model. J Urol 2004; 172 (6, Part 1): 2446-2550.
90. Elisseeff J, Anseth K, Sims D, McIntosh W, Randolph M, Langer R,. Transdermal photopolymerization for minimally invasive implantation. Proc Nat Acad Sci 1999; 96 (6): 3104.
91. Mironi-Harpaz I, Wang DY, Venkatraman S, Seliktar D,. Photopolymerization of cell-encapsulating hydrogels: crosslinking efficiency versus cytotoxicity. Acta Biomater 2012; 8 (5): 1838-1848.
92. Fairbanks BD, Schwartz MP, Bowman CN, Anseth KS,. Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6- trimethylbenzoylphosphinate: polymerization rate and cytocompatibility. Biomaterials 2009; 30 (35): 6702-6707.
93. Autian J,. Structure-toxicity relationships of acrylic monomers. Environ health Perspect 1975; 11: 141.
94. Dillingham E, Lawrench W, Autian J, Schmalz G,. Acrylate and methacrylate esters: relationship of hemolytic activity and in vivo toxicity. J Biomed Mater Res 1983; 17 (6): 945-957.
95. Ghanayem B, Maronpot R, Matthews H,. Ethyl acrylate-induced gastric toxicity: II. Structure-toxicity relationships and mechanism. Toxicol Appl Pharmacol 1985; 80 (2): 336-344.
96. Chan, K, O'Brien PJ,. Structure-activity relationships for hepatocyte toxicity and electrophilic reactivity of α, β-unsaturated esters, acrylates and methacrylates. J Appl Toxicol 2008; 28 (8): 1004-1015.
97. Freidig A, Mofhuis M, Van Holstijn I, Hermens J,. Glutathione depletion in rat hepatocytes: a mixture toxicity study with α, β-unsaturated esters. Xenobiotica 2001; 31 (5): 295-307.
98. Potter DW, and, Tran TB,. Rates of ethyl acrylate binding to glutathione and protein. Toxicol Lett 1992; 62 (2): 275-285.
99. Burdick JA, Peterson AJ, Anseth KS,. Conversion and temperature profiles during the photoinitiated polymerization of thick orthopaedic biomaterials. Biomaterials 2001; 22 (13): 1779-1786.
100. Kretlow JD, Klouda L, Mikos AG,. Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59 (4-5): 263-273.
101. Kretlow JD, Young S, Klouda L, Wong M, Mikos AG,. Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater 2009; 21 (32-33): 3368-3393.
102. Williams CG, Malik AN, Kim TK, Manson PN, Elisseeff JH,. Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation. Biomaterials 2005; 26 (11): 1211-1218.
103. Hou Q, De Bank PA, Shakesheff KM,. Injectable scaffolds for tissue regeneration. J Mater Chem 2004; 14 (13): 1915-1923.
104. Malgosia MP, Brian GB, Molly SS,. Injectable hydrogels for central nervous system therapy. Biomed Mater 2012; 7 (2): 024101.
105. He X, Jabbari E,. Material properties and cytocompatibility of injectable MMP degradable poly(lactide ethylene oxide fumarate) hydrogel as a carrier for marrow stromal cells. Biomacromolecules 2007; 8 (3): 780-792.
106. Pereira IHL, Ayres E, Patricio PS, Goes AM, Gomide VS, Junior EP, Orefice RL,. Photopolymerizable and injectable polyurethanes for biomedical applications: synthesis and biocompatibility. Acta Biomater 2010; 6 (8): 3056-3066.
107. Bergstrom K, Holmberg K, Safranj A, Hoffman AS, Edgell MJ, Kozlowski A, Hovanes BA, Harris JM,. Reduction of fibrinogen adsorption on peg-coated polystyrene surfaces. J Biomed Mater Res 1992; 26 (6): 779-790.
108. Gombotz WR, Guanghui W, Horbett TA, Hoffman AS,. Protein adsorption to poly (ethylene oxide) surfaces. J Biomed Mater Res 1991; 25 (12): 1547-1562.
109. Hern DL, Hubbell JA,. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res 1998; 39 (2): 266-276.
110. Lutolf MP, Hubbell JA,. Cell-responsive synthetic hydrogels. Adv Mater 2003; 15 (11): 888-892.
111. Burdick JA, Anseth KS,. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 2002; 23 (22): 4315-4323.
112. Bryant SJ, Anseth KS,. Controlling the spatial distribution of ECM components in degradable PEG hydrogels for tissue engineering cartilage. J Biomed Mater Res A 2003; 64A (1): 70-79.
113. Nakayama Y, Matsuda T,. Photocurable surgical tissue adhesive glues composed of photoreactive gelatin and poly (ethylene glycol) diacrylate. J Biomed Mater Res 1999; 48 (4): 511-521.
114. Cai L, Lu J, Sheen V, Wang S,. Promoting nerve cell functions on hydrogels grafted with poly(l-lysine). Biomacromolecules 2012; 13 (2): 342-349.
115. Tibbitt MW, Anseth KS,. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 2009; 103 (4): 655-663.
116. Weber LM, He J, Bradley B, Haskins K, Anseth KS,. PEG-based hydrogels as an in vitro encapsulation platform for testing controlled β-cell microenvironments. Acta Biomater 2006; 2 (1): 1-8.
117. Underhill GH, Chen AA, Albrecht DR, Bhatia N,. Assessment of hepatocellular function within PEG hydrogels. Biomaterials 2007; 28 (2): 256-270.
118. Tsang VL, Chen AA, Cho LM, Jadin KD, Sah RL, DeLong S, West JL, Bhatia SN,. Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels. FASEB J 2007; 21 (3): 790-801.
119. Wang H, et al., Injectable biodegradable hydrogels for embryonic stem cell transplantation: improved cardiac remodeling and function of myocardial infarction. J Cell Mole Med 2011; 16 (6): 1310-1320.
120. Bryant SJ, Arthur JA, Anseth KS,. Incorporation of tissue-specific molecules alters chondrocyte metabolism and gene expression in photocrosslinked hydrogels. Acta Biomater 2005; 1 (2): 243-252.
121. Bryant SJ, Anseth KS,. Encapsulating chondrocytes in degrading PEG hydrogels with high modulus: engineering gel structural changes to facilitate cartilaginous tissue production. Biotechnol Bioeng 2004; 86 (7): 747-755.
122. Lampe KJ, Mooney RG, Bjugstad KB, Mahoney MJ,. Effect of macromer weight percent on neural cell growth in 2D and 3D nondegradable PEG hydrogel culture. J Biomed Mater Res A 2010; 94A (4): 1162-1171.
123. Namba RM, Cole AA, Bjugstad KB, Mahoney MJ,. Development of porous PEG hydrogels that enable efficient, uniform cell-seeding and permit early neural process extension. Acta Biomater 2009; 5 (6): 1884-1897.
124. Park H, Temenoff JS, Tabata Y, Caplan AI, Mikos AG,. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 2007; 28 (21): 3217-3227.
125. Royce Hynes S, McGregor LM, Ford Rauch M, Lavik EB,. Photopolymerized poly(ethylene glycol)/poly(L-lysine) hydrogels for the delivery of neural progenitor cells. J Biomater Sci Polym Ed 2007; 18 (8): 1017-1030.
126. Klouda L, Perkins KR, Watson BM, Hacker MC, Bryant SJ, Raphael RM, Kurtis Kasper F, Mikos AG,. Thermoresponsive, in situ cross-linkable hydrogels based on N-isopropylacrylamide: fabrication, characterization and mesenchymal stem cell encapsulation. Acta Biomater 2011; 7 (4): 1460-1467.
127. Salinas CN, Anseth KS,. The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities. Biomaterials 2008; 29 (15): 2370-2377.
128. Bjugstad KB, Redmond Jr DE, Lampe KJ, Kern DS, Sladek JR, Mahoney MJ,. Biocompatibility of PEG-based hydrogels in primate brain. Cell Transpl 2008; 17 (4): 409-415.
129. Bjugstad KB, Lampe K, Kern DS, Mahoney M,. Biocompatibility of poly(ethylene glycol)-based hydrogels in the brain: an analysis of the glial response across space and time. J Biomed Mater Res A 2010; 95A (1): 79-91.
130. Khademhosseini A, Vacanti J, Langer R,. Progress in tissue engineering. Sci Am Mag 2009; 300 (5): 64-71.
131. Marois Y, Guidoin R,. Biocompatibility of polyurethanes. Madame Curie Bioscience Database [Internet]. Austin (TX): Landes Bioscience; 2000. Available from: http://www.ncbi.nlm.nih.gov/books/NBK5974/.
132. Vermette P, Griesser HJ, Laroche G, Guidoin R,. Biomedical applications of polyurethanes. Landes Biosci 2001. Landes Bioscience, Austin, TX.
133. Tanzi MC, Verderio P, Lampugnani MG, Tesnati M, Dejana E, Sturani E,. Cytotoxicity of some catalysts commonly used in the synthesis of copolymers for biomedical use. J Mater Sci Mater Med 1994; 5 (6): 393-396.
134. Szycher M, Szycher's Handbook of Polyurethanes, Boca Raton: CRC Press LLC; 1999.
135. Skarja G, Woodhouse K,. Structure-property relationships of degradable polyurethane elastomers containing an amino acid-based chain extender. J Appl Polym Sci 2000; 75 (12): 1522-1534.
136. Pauluhn J,. Inhalation toxicity of 1,6-hexamethylene diisocyanate homopolymer (HDI-IC) aerosol: results of single inhalation exposure studies. Toxicol Sci 2000; 58 (1): 173-181.
137. Karol MH, Dean JH,. Respiratory effects of inhaled isocyanates. CRC Crit Rev Toxicol 1986; 16 (4): 349-379.
138. Guelcher SA, Srinivansan A, Dumas JE, Didier JE, McBride S, Hollinger JO,. Synthesis, mechanical properties, biocompatibility, and biodegradation of polyurethane networks from lysine polyisocyanates. Biomaterials 2008; 29 (12): 1762-1775.
139. Kobayashi H, Hyon SH, Ikada Y,. Water-curable and biodegradable prepolymers. J Biomed Mater Res 1991; 25 (12): 1481-1494.
140. Butcher BT, Salvaggio JE, Weill H, Ziskind MM,. Toluene diisocyanate (TDI) pulmonary disease: immunologic and inhalation challenge studies. J Allergy Clin Immunol 1976; 58 (1): 89-100.
141. Vock EH, Lutz WK,. Distribution and DNA adduct formation of radiolabeled methylenediphenyl-4, 4′-diisocyanate (MDI) in the rat after topical treatment. Toxicol Lett 1997; 92 (2): 93-100.
142. Bolognesi C, Baur X, Marczynski B, Norppa H, Sepai O, Sabbioni G,. Carcinogenic risk of toluene diisocyanate and 4, 4′-methylenediphenyl diisocyanate: epidemiological and experimental evidence. CRC Critical Rev Toxicol 2001; 31 (6): 737-772.
143. Kim MN, Jang JC, Lee IM, Lee HS, Yoon JS,. Toxicity and biodegradation of diamines. J Environ Sci Health B 2002; 37 (1): 53-64.
144. Batich C, Williams J, King R,. Toxic hydrolysis product from a biodegradable foam implant. J Biomed Mater Res 1989; 23 (S14): 311-319.
145. Schoental R,. Carcinogenic and chronic effects of 4, 4′- diaminodiphenylmethane, an epoxyresin hardener. 1968; 219 (5159): 1162-1163.
146. Adolph EJ, Hafeman AE, Davidson JM, Nanney LB, Guelcher SA,. Injectable polyurethane composite scaffolds delay wound contraction and support cellular infiltration and remodeling in rat excisional wounds. J Biomed Mater Res A 2012; 100A (2): 450-461.
147. Dumas JE, Zienkiewicz K, Tanner SA, Prieto EM, Bhattacharyya S, Guelcher SA,. Synthesis and characterization of an injectable allograft bone/polymer composite bone void filler with tunable mechanical properties. Tissue Eng A 2010; 16 (8): 2505-2518.
148. Guelcher S, Srinivasan A, Hafeman A, Gallagher K, Doctor J, Khetan S, McBride S, Hollinger JO,. Synthesis, In vitro degradation, and mechanical properties of two-component poly(ester urethane)urea scaffolds: effects of water and polyol composition. Tissue Eng 2007; 13: 2321-2333.
149. Guelcher SA, Patel V, Gallagher KM, Connolly S, Didier JE, Doctor JS, Hollinger JO,. Synthesis and in vitro biocompatibility of injectable polyurethane foam scaffolds. Tissue Eng 2006; 12 (5): 1247-1259.
150. Hafeman A, Li B, Yoshii T, Zienkiewicz K, Davidson J, Guelcher SA,. Injectable biodegradable polyurethane scaffolds with release of platelet-derived growth factor for tissue repair and regeneration. Pharm Res 2008; 25 (10): 2387-2399.
151. Zhang JY, Beckman EJ, Piesco NP, Agarwal S,. A new peptide-based urethane polymer: synthesis, biodegradation, and potential to support cell growth in vitro. Biomaterials 2000; 21 (12): 1247-1258.
152. Zhang JY, Beckman EJ, Hu J, Yang GG, Agarwal S, Hollinger JO,. Synthesis, biodegradability, and biocompatibility of lysine diisocyanate-glucose polymers. Tissue Eng 2002; 8 (5): 771-785.
153. Duarte AP, Coelho JF, Bordado JC, Cidade MT, Gil MH,. Surgical adhesives: systematic review of the main types and development forecast. Prog Polym Sci 2012; 37 (8): 1031-1050.
154. Gilbert TW, Badylak SF, Beckman EJ, Clower DM, Rubin JP,. Prevention of seroma formation with TissuGlu((R)) surgical adhesive in a canine abdominoplasty model: long term clinical and histologic studies. J Plast Reconstr Aesthet Surg 2012; 66 (3): 414-422.
155. Gilbert TW, Badylak SF, Gusenoff J, Beckman EJ, Clower DM, Daly P, Rubin JP,. Lysine-derived urethane surgical adhesive prevents seroma formation in a canine abdominoplasty model. Plast Reconstr Surg 2008; 122 (1): 95-102.
156. Walgenbach KJ, Bannasch H, Kalthoff S, Rubin JP,. Randomized, prospective study of TissuGlu(R) surgical adhesive in the management of wound drainage following abdominoplasty. Aesthet Plast Surg 2012; 36 (3): 491-496.
157. Adolph EJ, Hafeman AE, Davidson JM, Nanney LB, Guelcher SA,. Injectable polyurethane composite scaffolds delay wound contraction and support cellular infiltration and remodeling in rat excisional wounds. J Biomed Mater Res A 2012; 100A (2): 450-461.
158. Hafeman AE, Zienkiewicz KJ, Zachman AL, Sung HJ, Nanney LB, Davidson JM, Guelcher SA,. Characterization of the degradation mechanisms of lysine-derived aliphatic poly (ester urethane) scaffolds. Biomaterials 2011; 32 (2): 419-429.
159. Nelson CE, Gupta MK, Adolph EJ, Shannon JM, Guelcher SA, Duvall CL,. Sustained local delivery of siRNA from an injectable scaffold. Biomaterials 2012; 33 (4): 1154-1161.
160. Dumas JE, Davis T, Holt GE, Yoshii T, Perrien DS, Nyman JS, Boyce T, Guelcher SA,. Synthesis, characterization, and remodeling of weight-bearing allograft bone/polyurethane composites in the rabbit. Acta Biomater 2010; 6 (7): 2394-2406.
161. Adhikari R, Gunatillake PA, Griffiths I, Tatai L, Wickramaratna M, Houshyar S, Moore T, Mayadunne R, Field J, McGee M,. Biodegradable injectable polyurethanes: synthesis and evaluation for orthopaedic applications. Biomaterials 2008; 29 (28): 3762-3770.
162. Yoshii T, Dumas JE, Okawa A, Spengler DM, Guelcher SA,. Synthesis, characterization of calcium phosphates/polyurethane composites for weight-bearing implants. J Biomed Mater Res B 2012; 100B (1): 32-40.
163. Jerald ED, BrownBaer PB, Prieto EM, Guda T, Hale RG, Wenke JC, Guelcher SA,. Injectable reactive biocomposites for bone healing in critical-size rabbit calvarial defects. Biomed Mater 2012; 7 (2): 024112.
164. DeForest CA, Polizzotti BD, Anseth KS,. Sequential click reactions for synthesizing and patterning three-dimensional cell microenvironments. Nat Mater 2009; 8 (8): 659-664.
165. Golas PL, Matyjaszewski K,. Marrying click chemistry with polymerization: expanding the scope of polymeric materials. Chem Soc Rev 2010; 39 (4): 1338-1354.
166. Hoyle CE, Bowman CN,. Thiol-Ene click chemistry. Angew Chem Int Ed 2010; 49 (9): 1540-1573.
167. Crescenzi V, Cornelio L, Di Meo C, Nardecchia S, Lamanna R,. Novel hydrogels via click chemistry: synthesis and potential biomedical applications. Biomacromolecules 2007; 8 (6): 1844-1850.
168. Kennedy DC, McKay CS, Legault MCB, Danielson DC, Blake JA, Pegoraro AF, Stolow A, Mester Z, Pezacki JP,. Cellular consequences of copper complexes used to catalyze bioorthogonal click reactions. J Am Chem Soc 2011; 133 (44): 17993-18001.
169. Xu J, Filion TM, Prifti F, Song J,. Cytocompatible poly(ethylene glycol)-co-polycarbonate hydrogels cross-linked by copper-free, strain-promoted click chemistry. Chem Asian J 2011; 6 (10): 2730-2737.
170. DeForest CA, Sims EA, Anseth KS,. Peptide-functionalized click hydrogels with independently tunable mechanics and chemical functionality for 3D cell culture. Chem Mater 2010; 22 (16): 4783-4790.
171. Hoyle CE, Lee TY, Roper T,. Thiol-enes: chemistry of the past with promise for the future. J Polym Sci A 2004; 42 (21): 5301-5338.
172. Lowe AB,. Thiol-ene "click" reactions and recent applications in polymer and materials synthesis. Polym Chem 2010; 1 (1): 17-36.
173. Lutolf MP, Hubbell JA,. Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by michael-type addition. Biomacromolecules 2003; 4 (3): 713-722.
174. Lutolf MP, Tirelli N, Cerritelli S, Cavalli L, Hubbell JA,. Systematic modulation of michael-type reactivity of thiols through the use of charged amino acids. Bioconjug Chem 2001; 12 (6): 1051-1056.
175. Shu XZ, Ahmad S, Liu Y, Prestwich GD,. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. J Biomed Mater Res A 2006; 79A (4): 902-912.
176. Duflo S, Thibeault SL, Li W, Shu XZ, Prestwich GD,. Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng 2006; 12 (8): 2171-2180.
177. Thibeault SL, Klemuk SA, Chen X, Quinchia Johnson BH,. In vivo engineering of the vocal fold ECM with injectable HA hydrogels-Late effects on tissue repair and biomechanics in a rabbit model. J Voice 2011; 25 (2): 249-253.
178. Liu, Y, Shu XZ, Prestwich GD,. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng 2006; 12 (12): 3405-3416.
179. Park AH, Hughes CW, Jackson A, Hunter L, McGill L, Simonsen SE, Alder SC, Shu XZ, Prestwich GD,. Crosslinked hydrogels for tympanic membrane repair. Otolaryngol Head Neck Surg 2006; 135 (6): 877-883.
180. Horn EM, Beaumont M, Shu XZ, Harvey A, Prestwich GD, Horn KM, Gibson AR, Preul M, Panitch A,. Influence of cross-linked hyaluronic acid hydrogels on neurite outgrowth and recovery from spinal cord injury. J Neurosurg Spine 2007; 6 (2): 133-140.
181. Nair LS, Laurencin CT,. Biodegradable polymers as biomaterials. Prog Polym Sci 2007; 32 (8-9): 762-798.
182. Kumbar SG, Bhattacharyya S, Nukavarapu SP, Khan YM, Nair LS, Laurencin CT,. In vitro and in vivo characterization of biodegradable poly (organophosphazenes) for biomedical applications. J Inorg Organomet Polym Mater 2006; 16 (4): 365-385.
183. Nair L, Laurencin C,. Polymers as biomaterials for tissue engineering and controlled drug delivery. Tissue Eng I 2006;102: 47-90.
184. Nair LS, Lee DA, Bender JS, Barrett EW, Greish YE, Brown PW, Allcock HR, Laurencin CT,. Synthesis, characterization, and osteocompatibility evaluation of novel alanine-based polyphosphazenes. J Biomed Mater Res A 2006; 76 (1): 206-213.
185. Sethuraman S, Nair LS, El-Amin S, Nguyen MT, Singh, A, Krogman N, Greish YE, Allcock HR, Brown PW, Laurencin CT,. Mechanical properties and osteocompatibility of novel biodegradable alanine based polyphosphazenes: side group effects. Acta Biomater 2010; 6 (6): 1931-1937.
186. Potta T, Chun C, Song SC,. Chemically crosslinkable thermosensitive polyphosphazene gels as injectable materials for biomedical applications. Biomaterials 2009; 30 (31): 6178-6192.
187. Potta T, Chun C, Song SC,. Injectable, dual cross-linkable polyphosphazene blend hydrogels. Biomaterials 2010; 31 (32): 8107-8120.
188. Potta T, Chun C, Song SC,. Design of polyphosphazene hydrogels with improved structural properties by use of star-shaped multithiol crosslinkers. Macromol Biosci 2011; 11 (5): 689-699.
189. Ossipov DA, Brannvall K, Forsberg-Nilsson K, Hilborn J,. Formation of the first injectable poly(vinyl alcohol) hydrogel by mixing of functional PVA precursors. J Appl Polym Sci 2007; 106 (1): 60-70.
190. Luo Y, Kobler JB, Heaton JT, Lia X, Zeitels SM, Langer R,. Injectable hyaluronic acid-dextran hydrogels and effects of implantation in ferret vocal fold. J Biomed Mater Res B 2010; 93B (2): 386-393.
191. Luo, Y, Kirker KR, Prestwich GD,. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Release, 2000; 69 (1): 169-184.
192. Bulpitt P, Aeschlimann D,. New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res 1999; 47 (2): 152-169.
193. Alves MH, Young CJ, Bozzetto K, Poole-Warren LA, Martens PJ,. Degradable, click poly(vinyl alcohol) hydrogels: characterization of degradation and cellular compatibility. Biomed Mater 2012; 7 (2): 024106.
194. Ossipov DA, Piskounova S, Hilborn JN,. Poly(vinyl alcohol) cross-linkers for in vivo injectable hydrogels. Macromolecules 2008; 41 (11): 3971-3982.
195. Hoffman AS,. Molecular bioengineering of biomaterials in the 1990s and beyond: a growing liaison of polymers with molecular biology. Artif Organs 1992; 16 (1): 43-49.
196. Fox RJ, Huisman GW,. Enzyme optimization: moving from blind evolution to statistical exploration of sequence-function space. Trends Biotechnol 2008; 26 (3): 132-138.
197. Wiseman A, Goldfarb PS, Woods L, Ridgway T,. Novel biocatalytic enzymes by directed evolution. Trends Biotechnol 2001; 19 (10): 382-392.
198. Lin CC, Anseth KS,. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res 2009; 26 (3): 631-643.
199. Kagan HM, Simpson DE, Tseng L,. Substrate-directed modulation of elastin oxidation by lysyl oxidase. Connect Tissue Res 1981; 8 (3-4): 213-217.
200. Kagan HM, Simpson DE, Tseng L,. Repeat polypeptide models of elastin as substrates for lysyl oxidase. J Biol Chem 1980; 255 (8): 3656-3659.
201. Urry DW,. 1986. Enzymatically Crosslinked Bioelastomers. U.S. Patent 4,589,882 filed Sept. 19, 1983 and issued May 20, 1986.
202. Stephan P,. An Assessment of the Small Business Innovation Research Program at the National Institutes of Health. In CW Wessner editor. Washington, DC: National Academies Press; 2009.
203. Davis NE, Ding S, Forster RE, Pinkas DM, Barron AE,. Modular enzymatically crosslinked protein polymer hydrogels for in situ gelation. Biomaterials 2010; 31 (28): 7288-7297.
204. Hu BH, Messersmith PB,. Enzymatically cross-linked hydrogels and their adhesive strength to biosurfaces. Orthod Craniofac Res 2005; 8 (3): 145-149.
205. Jin R, Hiemstra C, Zhong Z, Feijen J,. Enzyme-mediated fast in situ formation of hydrogels from dextran-tyramine conjugates. Biomaterials 2007; 28 (18): 2791-2800.
206. Jin R, Moreria Teixeira L, Dijkstra P, van Blitterswijk C, Karperien M, Feijen J,. Enzymatically-crosslinked injectable hydrogels based on biomimetic dextran-hyaluronic acid conjugates for cartilage tissue engineering. Biomaterials 2010; 31 (11): 3103-3113.
207. Jin R, Teixeria LSM, Dijkstra PJ, van Blitterswijk CA, Karperien M, Feijen J,. Chondrogenesis in injectable enzymatically crosslinked heparin/dextran hydrogels. J Control Release 2011; 152 (1): 186-195.
208. Kurisawa M, et al., Injectable enzymatically crosslinked hydrogel system with independent tuning of mechanical strength and gelation rate for drug delivery and tissue engineering. J Mater Chem 2010; 20 (26): 5371-5375.
209. Kuwahara K, et al., Cell delivery using an injectable and adhesive transglutaminase-gelatin gel. Tissue Eng C Methods 2009; 16 (4): 609-618.
210. Lee, F, Chung JE, Kurisawa M,. An injectable enzymatically crosslinked hyaluronic acid-tyramine hydrogel system with independent tuning of mechanical strength and gelation rate. Soft Matter 2008; 4 (4): 880-887.
211. Sakai S, et al., An injectable, in situ enzymatically gellable, gelatin derivative for drug delivery and tissue engineering. Biomaterials 2009; 30 (20): 3371-3377.
212. Wang, L.-S., et al., Injectable biodegradable hydrogels with tunable mechanical properties for the stimulation of neurogenesic differentiation of human mesenchymal stem cells in 3D culture. Biomaterials 2010; 31 (6): 1148-1157.
213. Sperinde JJ, Griffith LG,. Synthesis and characterization of enzymatically-cross-linked poly (ethylene glycol) hydrogels. Macromolecules 1997; 30 (18): 5255-5264.
214. Sperinde JJ, Griffith LG,. Control and prediction of gelation kinetics in enzymatically cross-linked poly (ethylene glycol) hydrogels. Macromolecules 2000; 33 (15): 5476-5480.
215. McHale MK, Setton LA, Chilkoti A,. Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair. Tissue Eng 2005; 11 (11-12): 1768-1779.
216. Breen A, O'Brien T, Pandit A,. Fibrin as a delivery system for therapeutic drugs and biomolecules. Tissue Eng B Rev 2009; 15 (2): 201-214.
217. Achneck HE, et al., A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Annal Surg 2010; 251 (2): 217.
218. Randleman CD, et al., Persistence of antibodies to the topical hemostat bovine thrombin. J Am Coll Surg 2010; 211 (6): 798-803.
219. Holy CE, et al., Optimizing the sterilization of PLGA scaffolds for use in tissue engineering. Biomaterials 2000; 22 (1): 25-31.
220. Noah EM, et al., Impact of sterilization on the porous design and cell behavior in collagen sponges prepared for tissue engineering. Biomaterials 2002; 23 (14): 2855-2861.
221. Zhang YZ, et al., Tissue response to commercial silicone and polyurethane elastomers after different sterilization procedures. Biomaterials 1996; 17 (23): 2265-2272.
222. Memisoglu-Bilensoy E, Hincal AA,. Sterile, injectable cyclodextrin nanoparticles: effects of gamma irradiation and autoclaving. Int J Pharm 2006; 311 (1-2): 203-208.
223. Zahraoui C, Sharrock P,. Influence of sterilization on injectable bone biomaterials. Bone 1999; 25 (2, Supplement 1): 63S-65S.
224. Matricardi P, et al., In situ cross-linkable novel alginate-dextran methacrylate IPN hydrogels for biomedical applications: mechanical characterization and drug delivery properties. Biomacromolecules 2008; 9 (7): 2014-2020.
225. Dillow AK, et al., Bacterial inactivation by using near- and supercritical carbon dioxide. Proce Nat Acad Sci 1999; 96 (18): 10344-10348.
226. White A, Burns D, Christensen TW,. Effective terminal sterilization using supercritical carbon dioxide. J Biotechnol 2006; 123 (4): 504-515.
227. Timmer MD, et al., In vitro cytotoxicity of injectable and biodegradable poly(propylene fumarate)-based networks: unreacted macromers, cross-linked networks, and degradation products. Biomacromolecules 2003; 4 (4): 1026-1033.
228. Wells LA, Furukawa S, Sheardown H,. Photoresponsive PEG-anthracene grafted hyaluronan as a controlled-delivery biomaterial. Biomacromolecules 2011; 12 (4): 923-932.
229. Pritchard CD, et al., An injectable thiol-acrylate poly(ethylene glycol) hydrogel for sustained release of methylprednisolone sodium succinate. Biomaterials 2011; 32 (2): 587-597.
230. Quinn JV,. Tissue Adhesives in Clinical Medicine. Vol. 1. BC Decker, Hamilton, Ontario; 2005.